Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)

Market Cap	3.14B
Revenue (ttm)	1.01B
Net Income (ttm)	120.37M
Shares Out	105.91M
EPS (ttm)	1.15
PE Ratio	25.82
Forward PE	n/a
Dividend	0.25 (0.84%)
Ex-Dividend Date	May 29, 2025

Volume	3,002,574
Average Volume	2,891,335
Open	29.05
Previous Close	29.81
Day's Range	29.05 - 29.90
52-Week Range	22.30 - 34.02
Beta	-0.36
RSI	62.46
Earnings Date	Aug 28, 2025

About SHE:002864

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was founded in 1997 and is based in Xi'an, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 933
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002864

Financial Performance

In 2024, SHE:002864's revenue was 973.86 million, a decrease of -0.71% compared to the previous year's 980.83 million. Earnings were 120.27 million, an increase of 8.91%.